Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators

Singapore Medical Journal

Volumn 49, Issue 4, 2008, Pages 333-338

  Than, Than Htwe ^a,c   Swethadri, G K ^a   Wong, J ^b   Ahmad, T ^b   Jamil, D ^b   Maganlal, R K ^b   Hamdi, M M ^a   Abdullah, M S ^a  

^a UNIVERSITI MALAYSIA SARAWAK   (Malaysia)

^b SARAWAK GENERAL HOSPITAL   (Malaysia)

^c UNIVERSITI KUALA LUMPUR   (Malaysia)

Author keywords

Galectin 3; Galectin 7; Immunohistochemistry; Thyroid malignancy

Indexed keywords

GALECTIN 3; GALECTIN 7; PROTEIN ANTIBODY;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; THYROID CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; CARCINOMA, PAPILLARY; GALECTIN 3; GALECTINS; GOITER, NODULAR; HUMANS; IMMUNOHISTOCHEMISTRY; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 44149116713     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ringel MD, Ladenson PW. Controversies in the follow-up and management of well-differentiated thyroid cancer. Endocr Relat Cancer 2004; 11:97-116.
2. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998; 83:2638-48.
3. Herdinger C, Sobin LH. Histological typing of thyroid tumors. 2nd ed. In: World Health Organization. International Histological Classification of Tumours. Berlin: Springer-Verlag, 1974.
4. Hirokawa M, Carney JA, Goellner JR, et al. Observer variation of encapsulated follicular lesions of the thyroid gland. Am J Surg Pathol 2002; 26:1508-14.
5. Franc B, de la Salmonière P, Lange F, et al. Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma. Hum Pathol 2003; 34:1092-1100.
6. Barondes SH, Castronovo V, Cooper DN, et al. Galectins: a family of animal beta-galactoside-binding lectins. Cell 1994; 76:597-98.
7. Barondes SH, Cooper DN, Gitt MA, Leffler H. Galectins. Structure and function of a large family of animal lectins. J Biol Chem 1994; 269:20807-10.
8. Kasai K, Hirabayashi J. Galectins: a family of animal lectins that decipher glycocodes. J Biochem 1996; 119:1-8.
9. Hughes RC. Galectins as modulators of cell adhesion. Biochimie 2001; 83:667-76.
10. Hirabayashi J. Recent topics on galectins. Trends Glycosci Glycotechnol 1997; 9:1-180.
11. Perillo NL, Marcus ME, Baum LG. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med 1998; 76:402-12.
12. Chiariotti L, Berlingieri MT, De Rosa P. Increased expression of the negative growth factor, galactoside-binding protein, gene in transformed thyroid cells and in human thyroid carcinomas. Oncogene 1992; 7:2507-11.
13. Chiariotti L, Berlingieri MT, Battaglia C, et al. Expression of galectin-1 in normal human thyroid gland and in differentiated and poorly differentiated thyroid tumors. Int J Cancer 1995; 64:171-5.
14. Xu XC, el-Naggar AK, Lotan R. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am J Pathol 1995; 147: 815-22.
15. Fernández PL, Merino MJ, Gómez M, et al. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. J Pathol 1997; 181: 80-86.
16. Cvejic D, Savin S, Paunovic I, et al. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. Anticancer Res 1998; 18(4A):2637-41.
17. Orlandi F, Saggiorato E, Pivano G, et al. Galectin-3 is a presurgical marker of human thyroid carcinoma. Cancer Res 1998; 58: 3015-20.
18. Kawachi K, Matsuchita Y, Yonezawa S, et al. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation. Hum Pathol 2000; 31:428-33.
19. Danguy A, Camby I, Kiss R. Galectins and cancer. Biochima Biophys Acta 2002; 1572:285-93.
20. Rorive S, Eddafali B, Fernandez S, et al. Changes in galectin-7 and cytokeratin-19 expression during the progression of malignancy in thyroid tumors: diagnostic and biological implications. Mod Pathol 2002; 15:1294-301.
21. Gasbarri A, Martegani MP, Del Prete F, et al. Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. J. Clin Oncol 1999; 17:3494-502.
22. Inohara H, Akahani S, Koths K, Raz A. Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion. Cancer Res 1996; 56:4530-4.
23. Coli A, Bigotti G, Zucchetti F, Negro F, Massi G. Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia. Histopathology 2002; 40:80-7.
24. Kawachi K, Matsushita Y, Yonezawa S, et al. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation. Hum Pathol 2000; 31:428-33.
25. Cvejic DS, Savin SB, Petrovic IM, et al. Galectin-3 expression in papillary thyroid carcinoma: Relation to histomorphologic growth pattern, lymph node metastasis, extrathyroid invasion, and tumor size. Head Neck 2005; 27:1049-55.
26. Saggiorato E, Cappia S, De Giuli P, et al. Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. J Clin Endocrinol Metab 2001; 86:5152-8.
27. Jakubiak-Wielganowicz M, Kubiak R, Sygut J, Pomorski L, Kordek R. Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma. Pol J Pathol 2003; 54:111-5.
28. Mehrotra P, Okpokam A, Bouhaida R, et al. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms. Histopathology 2004; 45:493-500.
29. Davies R, Barakat M, Meeran K, Dina R. Galectin-3 staining of benign and malignant thyroid lesions - is it a useful diagnostic tool? In: Endocrine abstracts[online]. Available at: www.endocrine-abstracts. org/ea/0007/ea0007p76. htm. Accessed March 27, 2006
30. Martins L, Matsuo SE, Ebina KN, et al. Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors. J Clin Endocrinol Metab 2002; 87:4806-10.
31. Herrmann ME, LiVolsi VA, Pasha TL, et al. Immunohistochemical expression of Galectin-3 in benign and malignant thyroid lesions. Arch Pathol Lab Med 2002; 126:710-3.
32. Oestreicher-Kedem Y, Halpern M, Roizman P, et al. Diagnostic value of galectin-3 as a marker for malignancy in follicular patterned thyroid lesions. Head Neck 2004; 26:960-6.
33. Magnaldo T, Bernerd F, Darmon M. Galectin-7, a human 14-kDa S-lectin, specifically expressed in keratinocytes and sensitive to retinoic acid. Dev Biol 1995; 168:259-71.
34. Magnaldo T, Fowlis D, Darmon M. Galectin-7, a marker of all types of stratified epithelia. Differentiation 1998; 63:159-68.
35. Timmons PM, Colnot C, Cail I, Poirier F, Magnaldo T. Expression of galectin-7 during epithelial development coincides with the onset of stratification. Int J Dev Biol 1999; 43:229-35.
36. Ostergaard M, Rasmussen HH, Nielsen HV, et al. Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res 1997; 57:4111-7.
37. Bernerd F, Sarasin A, Magnaldo T. Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes. Proc Natl Acad Sci U S A 1999; 96:11329-34.